1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, December 2016 (p10)

Drug Discovery and Development Analysis & Statistics, December 2016 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

271-300 of about 2500 reports

Purchase Reports From Reputable Market Research Publishers

Meningitis - Pipeline Review, H2 2016

Meningitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Meningitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States, World
Huntington Disease - Pipeline Review, H2 2016

Huntington Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Huntington Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Aplastic Anemia - Pipeline Review, H2 2016

Aplastic Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Kaposi Sarcoma - Pipeline Review, H2 2016

Kaposi Sarcoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Kaposi Sarcoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kaposi Sarcoma – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States
Ventricular Tachycardia - Pipeline Review, H2 2016

Ventricular Tachycardia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Ventricular Tachycardia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia - Pipeline Review, H2 2016, provides ...

  • Industries : Therapy, Chronic Disease, Pathology, Drug Discovery and Development
  • Countries : World
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016

Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Vaso-Occlusive Crisis ...

  • Industries : Pathology
  • Countries : United States
Hemochromatosis - Pipeline Review, H2 2016

Hemochromatosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hemochromatosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hemochromatosis - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States, World
Gouty Arthritis (Gout) - Pipeline Review, H2 2016

Gouty Arthritis (Gout) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Gouty Arthritis (Gout) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis (Gout) – Pipeline Review, H2 2016, provides ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : United States, World
Macular Edema - Pipeline Review, H2 2016

Macular Edema - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Macular Edema - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Pathology
  • Countries : United States
Diabetic Neuropathy - Pipeline Review, H2 2016

Diabetic Neuropathy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Diabetic Neuropathy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States
Irritable Bowel Syndrome - Pipeline Review, H2 2016

Irritable Bowel Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Irritable Bowel Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome – Pipeline Review, H2 2016, provides ...

  • Industries : Pathology
  • Countries : United States
Tuberculosis - Pipeline Review, H2 2016

Tuberculosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Tuberculosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States, World
Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016

Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dry (Atrophic) Macular Degeneration – Pipeline ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Malaria - Pipeline Review, H2 2016

Malaria - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Malaria - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Diabetic Retinopathy - Pipeline Review, H2 2016

Diabetic Retinopathy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Diabetic Retinopathy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Critical Limb Ischemia - Pipeline Review, H2 2016

Critical Limb Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Critical Limb Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia – Pipeline Review, H2 2016, provides ...

  • Industries : Biological Therapy, Chronic Disease, Pathology, Therapy
  • Countries : United States
Muscular Dystrophy - Pipeline Review, H2 2016

Muscular Dystrophy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Muscular Dystrophy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Mental Health, Pathology
  • Countries : United States
LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists - Pipeline Insights, 2016

LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists - Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonists, TIM-3 Antagonists & ...

  • Industries : Drug Discovery and Development
Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

  • $ 1000
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by ...

  • Industries : Pharmaceutical, Biotechnology, Biological Therapy, Biopharmaceutical, Drug Discovery and Development, Generic Drug, Therapy
  • Countries : Japan, Asia
SPR Therapeutics, LLC - Product Pipeline Analysis, 2016 Update

SPR Therapeutics, LLC - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • October 2016
  • by Global Data

Summary SPR Therapeutics, LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes ...

  • Industries : Therapy
  • Countries : United States
Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

Description “Oncology drug report - Votrient - pazopanib - 2009-2015 analysis; 2016-2021 expectations” is a comprehensive report on multi-tyrosine kinase inhibitor targeted therapy drug Votrient’s ...

  • Industries : Cancer, Therapy, Pathology, Pharmaceutical
  • Countries : United States, Europe
Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Adcetris: 2011-2015 analysis; 2016-2021 expectations” is a comprehensive report on the first and only approved drug of Seattle Genetics called Adcetris, which is also the first drug approved by the ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical, General Medicine and Specialty Medicine
  • Countries : United States
Clinical Research UK Industry Report

Clinical Research UK Industry Report

  • $ 449
  • Industry report
  • January 2017
  • by Plimsoll Publishing Ltd UK

Plimsoll’s UK Clinical Research (UK) analysis is the most definitive and accurate study of the Clinical Research (UK) sector in 2016. The report is split into two sections and uses both a written and ...

  • Industries : Drug Discovery and Development
  • Countries : United Kingdom
Oncology Drug Report: Zydelig | Idelalisib – 2011 -2016 analysis; 2017-2021 expectations

Oncology Drug Report: Zydelig | Idelalisib – 2011 -2016 analysis; 2017-2021 expectations

  • $ 300
  • Industry report
  • January 2017
  • by Cancer Research Analytics

Zydelig (idelalsib): strong start but not expected to continue” is a comprehensive report on the first-in-class, targeted, oral PI3K delta inhibitor approved drug for relapsed chronic lymphocytic leukemia ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States
Valchlor - mechlorethamine Oncology drug report : 2014-2015 analysis; 2016-2021 expectations

Valchlor - mechlorethamine Oncology drug report : 2014-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • December 2016
  • by Cancer Research Analytics

“Valchlor: First of its kind” is a comprehensive drug report about the first ap-proved topical formulation gel for mycosis fungoids cutaneous T-cell lymphoma (MF-CTCL). Valchlor is the only drug in ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Oncology drug report - Perjeta - pertuzumab - 2012-2015 analysis; 2016-2021 expectations

Oncology drug report - Perjeta - pertuzumab - 2012-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • December 2016
  • by Cancer Research Analytics

“Perjeta (pertuzumab): In the spotlight” is a comprehensive report on the first and only USFDA approved drug for eoadjuvant breast cancer treatment. Perjeta falls in the monoclonal antibody, HER2 dimerization ...

  • Industries : Therapy
  • Countries : Europe, Japan, World, Asia
Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations

Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • December 2016
  • by Cancer Research Analytics

“Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations” is a comprehensive drug report on the most controversial drug in recent times. Iclusig is the first and only ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Europe
Spaulding Clinical Research LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Spaulding Clinical Research LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2016
  • by Global Data

Summary Spaulding Clinical Research LLC (Spaulding Clinical Research) is a clinical research company that offers clinical pharmacology research. The company provide products such as spaulding electrocardiograph ...

  • Industries : Drug Discovery and Development
Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Translational Drug Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2016
  • by Global Data

Summary Translational Drug Development LLC (TD2) is a drug development organization that specializes in providing oncology treatments to cancer patients. The organization provides services such as regulatory ...

  • Industries : Drug Discovery and Development
The Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2016
  • by Global Data

Summary The Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and ...

  • Industries : Drug Discovery and Development
  • Countries : Canada

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.